Accelerate Diagnostics, Inc (AXDX) Financial Statements (2025 and earlier)

Company Profile

Business Address 3950 S. COUNTRY CLUB ROAD #470
TUCSON, AZ 85714
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:13,20045,60040,69836,18161,01466,260
Cash and cash equivalent12,13834,90539,89835,78161,01466,260
Short-term investments1,081900800400  
Other undisclosed cash, cash equivalents, and short-term investments(19)9,795    
Receivables2,6222,4162,3201,5503,2221,860
Inventory, net of allowances, customer advances and progress billings3,3105,1945,0679,2168,0597,746
Inventory3,3105,1945,0679,2168,0597,746
Prepaid expense3808187681,172955980
Other current assets1,5162,0251,5581,7801,165576
Other undisclosed current assets3,438(39)22,92032,08847,437100,218
Total current assets:24,46656,01473,33181,987121,852177,640
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization1,5182,422   
Operating lease, right-of-use asset1,1771,8592,5103,1833,917
Property, plant and equipment2,3893,4785,3896,1357,9057,303
Intangible assets, net (including goodwill)      114
Intangible assets, net (excluding goodwill)      114
Other noncurrent assets1,8161,2421,8172,120750208
Total noncurrent assets:6,9009,0019,71611,43812,5727,625
TOTAL ASSETS:31,36665,01583,04793,425134,424185,265
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,0397,1835,7455,5437,4417,546
Interest and dividends payable9091,2621,2621,262
Accounts payable4,7964,5011,9831,2902,3511,322
Accrued liabilities3,2432,6822,8532,9913,8284,962
Deferred revenue1,545547451376271
Debt1,30957,52680553450 
Contract with customer, liability217
Other undisclosed current liabilities1,1411,301669497  
Total current liabilities:12,03466,5576,9456,9698,1627,763
Noncurrent Liabilities
Long-term debt and lease obligation36,364782110,3657,722133,622120,074
Long-term debt, excluding current maturities36,102 107,9844,659130,043120,074
Finance lease, liability262782   
Liabilities, other than long-term debt2,85619,2778083351953
Deferred revenue1,122    
Due to related parties16,858    
Other liabilities1,1648748083351953
Operating lease, liability5701,5452,3813,0633,579
Other undisclosed noncurrent liabilities  663 141,211  
Total noncurrent liabilities:39,22020,722111,173149,268133,641120,127
Total liabilities:51,25487,279118,118156,237141,803127,890
Equity
Equity, attributable to parent, including:(19,888)(22,264)(35,071)(62,812)(7,379)57,375
Preferred stock  44   
Common stock14     
Treasury stock, value(45,067)(45,067)(45,067)(45,067)(45,067)(45,067)
Additional paid in capital694,634630,341580,652475,072452,344432,885
Accumulated other comprehensive income (loss)(612)(400)(60)91(58)(149)
Accumulated deficit(668,857)(607,239)(570,668)(492,966)(414,653)(330,348)
Other undisclosed equity, attributable to parent  9768585554
Total equity:(19,888)(22,264)(35,071)(62,812)(7,379)57,375
TOTAL LIABILITIES AND EQUITY:31,36665,01583,04793,425134,424185,265

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues12,05912,75211,78211,1659,2975,670
Cost of revenue
(Cost of Product and Service Sold)
(9,509)(9,449)(12,163)(6,706)(4,897)(3,187)
Gross profit:2,5503,303(381)4,4594,4002,483
Operating expenses(56,578)(66,108)(71,179)(68,159)(77,231)(82,852)
Operating loss:(54,028)(62,805)(71,560)(63,700)(72,831)(80,369)
Nonoperating income (expense)(6,740)235(6,097)(14,602)(11,158)(7,125)
Investment income, nonoperating1,123  (99)427621
Other nonoperating income (expense)108235(6,097)(14,503)(11,585)(7,746)
Interest and debt expense  (2,268)9,793(15,457)(600)(399)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes    15,556173(222)
Loss from continuing operations before equity method investments, income taxes:(60,768)(64,838)(67,864)(78,203)(84,416)(88,115)
Other undisclosed income (loss) from continuing operations before income taxes  2,268(9,793)   
Loss from continuing operations before income taxes:(60,768)(62,570)(77,657)(78,203)(84,416)(88,115)
Income tax expense (benefit)(850)77(45)(5)111(211)
Loss from continuing operations:(61,618)(62,493)(77,702)(78,208)(84,305)(88,326)
Loss before gain (loss) on sale of properties:(77,702)(78,208)(84,305)(88,326)
Net loss available to common stockholders, diluted:(61,618)(62,493)(77,702)(78,208)(84,305)(88,326)

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(61,618)(62,493)(77,702)(78,208)(84,305)(88,326)
Comprehensive loss:(61,618)(62,493)(77,702)(78,208)(84,305)(88,326)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(212)(340)(151)14991(149)
Comprehensive loss, net of tax, attributable to parent:(61,830)(62,833)(77,853)(78,059)(84,214)(88,475)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: